Amylyx Pharmaceuticals
AMLX
AMLX
78 hedge funds and large institutions have $513M invested in Amylyx Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
54% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 13
8% more funds holding
Funds holding: 72 → 78 (+6)
4.01% more ownership
Funds ownership: 41.48% → 45.48% (+4%)
Holders
78
Holding in Top 10
3
Calls
$25.6M
Puts
$11.3M
Top Buyers
| 1 | +$39.8M | |
| 2 | +$6.02M | |
| 3 | +$5.95M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.87M |
| 5 |
Belvedere Trading
Chicago,
Illinois
|
+$3.52M |
Top Sellers
| 1 | -$15.6M | |
| 2 | -$2.89M | |
| 3 | -$2.06M | |
| 4 |
Renaissance Technologies
New York
|
-$1.88M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1.68M |